Atsufumi Kawabata Selected Research

seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamide

7/2006	Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin.
9/2003	Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats.
6/2002	Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptor-2 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsufumi Kawabata Research Topics

Disease

52	Hyperalgesia 01/2021 - 06/2002
38	Pain (Aches) 02/2021 - 06/2003
15	Visceral Pain 01/2021 - 03/2004
11	Neoplasms (Cancer) 03/2022 - 06/2012
11	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 01/2016
11	Cystitis 01/2020 - 06/2011
10	Inflammation (Inflammations) 01/2021 - 12/2003
9	Pancreatitis 12/2017 - 05/2006
8	Hypersensitivity (Allergy) 02/2021 - 07/2006
7	Neuralgia (Stump Neuralgia) 12/2020 - 07/2010
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2015
5	Intractable Pain 01/2021 - 01/2011
5	Nociceptive Pain 01/2019 - 11/2010
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2020 - 06/2011
4	Edema (Dropsy) 01/2018 - 08/2006
3	Hypertension (High Blood Pressure) 01/2021 - 07/2004
2	Multiple Myeloma 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2008
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 05/2020
2	Disseminated Intravascular Coagulation 01/2019 - 11/2013
2	Referred Pain 01/2018 - 01/2012
2	Hyperthermia 01/2017 - 01/2017
2	Colitis 01/2014 - 10/2009

Drug/Important Bio-Agent (IBA)

17	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
16	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 11/2007
13	ThrombomodulinIBA 05/2021 - 11/2013
13	T-Type Calcium Channels (T-Type Calcium Channel)IBA 02/2021 - 03/2009
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 06/2011
12	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2012
11	sodium bisulfide (NaHS)IBA 01/2019 - 11/2007
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2009
9	CeruletideIBA 12/2017 - 05/2006
8	Thrombin FDA Link 01/2021 - 06/2002
8	Protein Isoforms (Isoforms)IBA 11/2020 - 07/2012
7	NNC 55-0396IBA 06/2019 - 01/2012
7	GasotransmittersIBA 02/2015 - 11/2007
6	CystathionineIBA 01/2020 - 10/2012
6	LyasesIBA 01/2020 - 10/2012
6	EnzymesIBA 01/2018 - 11/2007
5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2014
5	Pharmaceutical PreparationsIBA 01/2019 - 12/2003
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2018
4	Toll-Like Receptor 4IBA 01/2021 - 04/2014
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 11/2013
4	Neutralizing AntibodiesIBA 12/2020 - 11/2013
4	sodium sulfideIBA 11/2020 - 02/2014
4	Capsaicin (Zostrix)FDA Link 05/2020 - 06/2003
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 06/2012
4	LipopolysaccharidesIBA 01/2018 - 04/2014
4	Phenobarbital (Luminal)FDA Link 01/2018 - 03/2004
4	ProstaglandinsIBA 01/2018 - 01/2011
4	Cysteine (L-Cysteine)FDA Link 02/2016 - 11/2007
4	Analgesics (Analgesic Drugs)IBA 01/2016 - 08/2006
4	MibefradilIBA 10/2012 - 11/2007
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2006
3	Dihydrotachysterol (AT 10)IBA 01/2021 - 08/2006
3	Hormones (Hormone)IBA 01/2021 - 01/2019
3	Bortezomib (Velcade)FDA Link 01/2021 - 01/2019
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 04/2014
3	capsazepineIBA 05/2020 - 06/2002
3	AndrogensIBA 01/2019 - 10/2015
3	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
3	2-furoyl-LIGRLO-amideIBA 01/2018 - 05/2006
3	TrypsinIBA 05/2007 - 09/2003
3	seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA 07/2006 - 06/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2003 - 09/2002
2	AlbuminsIBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Estrogens (Estrogen)FDA Link 05/2021 - 01/2021
2	Butyrates (Butyrate)IBA 02/2021 - 11/2020
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Bepridil (Vascor)FDA Link 01/2021 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 12/2020 - 01/2016
2	PAR-2 ReceptorIBA 11/2020 - 11/2010
2	Substance PIBA 06/2020 - 01/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2017
2	Calcineurin InhibitorsIBA 05/2020 - 01/2017
2	CalcineurinIBA 05/2020 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	AntioxidantsIBA 01/2020 - 02/2015
2	Calcium Channels (Calcium Channel)IBA 07/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 11/2013
2	AsparagineIBA 01/2019 - 01/2017
2	Clodronic Acid (Clodronate)IBA 10/2018 - 12/2017
2	ethyl pyruvateIBA 10/2018 - 12/2017
2	prolinedithiocarbamate (PDTC)IBA 10/2018 - 01/2018
2	Alanine (L-Alanine)FDA Link 01/2018 - 01/2018
2	CurcuminIBA 01/2018 - 01/2010
2	ZincIBA 01/2018 - 02/2015
2	Protein Kinase CIBA 01/2017 - 01/2011
2	zinc chloride FDA Link 02/2015 - 07/2012
2	Ethosuximide (Zarontin)FDA LinkGeneric 02/2013 - 11/2007

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 03/2022 - 02/2013
6	Therapeutics 01/2022 - 11/2004
2	Ligation 01/2018 - 01/2018
2	Injections 12/2017 - 12/2015
2	Oral Administration 02/2013 - 11/2007